CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Option exercise | +32,903 | 280,132 | ||
| 2024-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Shares withheld for taxes | −24,408 | $2.62 | $64K | 255,724 |
| 2024-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Option exercise · Restricted Stock Units | −8,977 | 0 | ||
| 2024-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Option exercise · Restricted Stock Units | −25,666 | 25,667 | ||
| 2024-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Option exercise · Restricted Stock Units | −32,903 | 65,807 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise | +7,087 | 126,712 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise | +27,556 | 154,268 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise | +32,757 | 187,025 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Shares withheld for taxes | −24,353 | $2.62 | $64K | 162,672 |
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise · Restricted Stock Units | −7,087 | 0 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise · Restricted Stock Units | −27,556 | 27,557 | ||
| 2024-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Option exercise · Restricted Stock Units | −32,757 | 65,513 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Option exercise | +27,916 | 43,101 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Option exercise | +35,790 | 78,891 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Shares withheld for taxes | −31,265 | $2.62 | $82K | 47,626 |
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −27,916 | 27,917 | ||
| 2024-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −35,790 | 71,580 | ||
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +8,750 | 143,548 | ||
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +26,096 | 169,644 | ||
| 2024-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +33,457 | 203,101 |
Page 13 of 15 · 285 trades